Cargando…
Vaccinations in patients with immune-mediated inflammatory diseases
Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immunomodulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventa...
Autores principales: | Rahier, Jean-François, Moutschen, Michel, Van Gompel, Alfons, Van Ranst, Marc, Louis, Edouard, Segaert, Siegfried, Masson, Pierre, De Keyser, Filip |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936949/ https://www.ncbi.nlm.nih.gov/pubmed/20591834 http://dx.doi.org/10.1093/rheumatology/keq183 |
Ejemplares similares
-
Cancer risk in immune-mediated inflammatory diseases (IMID)
por: Beyaert, Rudi, et al.
Publicado: (2013) -
Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use
por: Hazes, Johanna M.W., et al.
Publicado: (2011) -
Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update
por: Segaert, Siegfried
Publicado: (2009) -
Emerging Pests and Vector-borne Diseases in Europe
por: Van Gompel, Alfons, et al.
Publicado: (2008) -
Gut Microbiota Associated with Clostridioides difficile Carriage in Three Clinical Groups (Inflammatory Bowel Disease, C. difficile Infection and Healthcare Workers) in Hospital Field
por: Martinez, Elisa, et al.
Publicado: (2023)